Results 41 to 50 of about 1,181 (167)
Background The purpose of this study was to analyse the impact of commissioned addenda by the Federal Joint Committee (FJC) to the HTA body (IQWiG) and their agreement with FJC decisions and to identify potential additional decisive factors of FJC ...
C. M. Dintsios +3 more
doaj +1 more source
Die Medizin der Zukunft braucht ein modernes AMNOG
Im Koalitionsvertrag steht: „Wir werden Deutschland zum weltweit innovativsten Chemie-, Pharma- und Biotechnologiestandort machen.“ Das ist eine kluge Entscheidung.
Alexandra Bishop
doaj +1 more source
Background Since the implementation of the Regulation on Patient Integration (2003), the Act on the Reorganization of the Pharmaceutical Market (2011), and the Patient Rights Law (2013), the inclusion of patient perspectives has been further anchored in ...
Ana Babac +2 more
doaj +1 more source
Ehrbarer Staat: Was hat Schwarz-Gelb bisher bewirkt? Eine Bewertung auf Basis der Generationenbilanz [PDF]
Nach einem Drittel der Legislaturperiode hat die im Herbst 2009 angetretene schwarz-gelbe Koalition aus CDU, CSU und FDP mit dem Wachstumsbeschleunigungsgesetz, dem Zukunftspaket und der Gesundheitsreform bis Ende 2010 wesentliche Ziele des ...
Moog, Stefan, Raffelhüschen, Bernd
core
Der Gesetzgeber hat mit dem 2019 eingeführten Instrument der anwendungsbegleitenden Datenerhebung (AbD) die Möglichkeit geschaffen, vergleichende Daten in der laufenden Versorgung zu erheben.
Dr. rer. nat. Matthias Wilken +1 more
doaj +1 more source
Training of personel who are engaged in food safety management system implementation and personel who handle with food is very important for efficiency of food safety management system.
Brane Novakovic +2 more
doaj +1 more source
Orphan drug considerations in Health Technology Assessment ineight European countries [PDF]
Health Technology Assessment (HTA) is used to assess the value of new technologies and by producing coverage recommendations it indirectly controls the uptake of new technologies in many European countries.
Kanavos, Panos +2 more
core
Does health technology assessment compromise access to pharmaceuticals? [PDF]
Büssgen M, Stargardt T.
europepmc +2 more sources
Why the drug development pipeline is not delivering better medicines [PDF]
Despite the large number of new medicines entering the market every year, the vast majority offer few clinical advantages for patients over existing alternatives.
Carter, Alexander W. +2 more
core +1 more source

